ProfileGDS4459 / ENSG00000158435
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 91% 87% 85% 88% 85% 86% 85% 85% 84% 86% 84% 85% 88% 87% 84% 79% 84% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 17.2591
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.6987
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.7485
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 46.6488
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.6985
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.6986
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.6885
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.6885
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.6884
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.7186
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.6384
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.885
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.9688
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.6887
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.6884
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.879
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.3984